Investing.com - Benitec Biopharma ADR reported on Monday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Benitec Biopharma ADR announced earnings per share of $-0.59 on revenue of $25K. Analysts polled by Investing.com anticipated EPS of $-104.47 on revenue of $0.05M.
Benitec Biopharma ADR shares are up 11.07% from the beginning of the year, still down 72.26% from its 52 week high of $10.49 set on March 23, 2021. They are outperforming the Nasdaq which is down 11.85% from the start of the year.
Benitec Biopharma ADR follows other major Healthcare sector earnings this month
Benitec Biopharma ADR's report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar